Back to Journals » Biologics: Targets and Therapy » Volume 9

Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib

Total article views   HTML views PDF downloads Totals
10,932 Dovepress* 10,489+ 1,760 12,249
PubMed Central* 443 152 595
Totals 10,932 1,912 12,844
*Since 19 February 2015
+Since July 2016

View citations on PubMed Central and Google Scholar